If you need more lookups,
subscriptions start at $34 USD/month.
Bruce Conway Location
New York, NY, US
Bruce Conway Work
2014 -now Director, Black Family Therapeutic Development Fund (formerly the Robertson TDF) @
2013 -now Entrepreneur In Residence @
2014 -now Adjunct Professor, Laboratory of Blood and Vascular Biology @
2012 -2015 Founder and Principal @ Conway Pharma Group Consulting
2013 -2014 Executive in Residence @ Columbia University
2006 -2012 Senior Director of Biology and Pharmacology @ The Institute for Drug Discovery
1996 -2006 Principal Scientist @
1992 -1996 Post-Doctoral Fellow @
Bruce Conway Education
UMass Chan Medical School
Post-Doctoral (Biochemistry)
1992-1996
Virginia Commonwealth University School of Medicine
Doctor of Philosophy (Ph.D.) (Pharmacology and Toxicology)
1987-1992
University of the Sciences in Philadelphia
Bachelor's Degree (Toxicology)
1983-1987
Bruce Conway Skills
Biomarkers
In Vitro
Assay Development
Pharmacology
Drug Discovery
In Vivo
Due-Diligence
Strategic Planning
Pharmaceutical Industry
Oncology
Medicinal Chemistry
Translational Medicine
Lifesciences
Biotechnology
Pharmacokinetics
Clinical Trials
DMPK
Therapeutic Areas
Metabolism
Due Diligence
Pharmaceutics
Cell
IND
Drug Development
Inflammation
CRO
R&D
Validation
Technology Transfer
Life Sciences
Cell Biology
Data Analysis
Science
Microsoft Excel
Bruce Conway Summary
Bruce Conway, based in New York, NY, US, is currently a Director, Black Family Therapeutic Development Fund (formerly the Robertson TDF) at The Rockefeller University. Bruce Conway brings experience from previous roles at Fiddlehead Foundation, The Rockefeller University, Conway Pharma Group Consulting and Columbia University. Bruce Conway holds a 1992 - 1996 Post-Doctoral in Biochemistry @ UMass Chan Medical School. With a robust skill set that includes Biomarkers, In Vitro, Assay Development, Pharmacology, Drug Discovery and more. Bruce Conway has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Bruce Conway?
Find contact details for 700 million professionals.